Pink Pill Will Boost A Woman’s Sex Life

It was 17 years ago when Viagra launched on the market for men, and it was just announced that women will soon have their own little ‘blue pill’ solution that will make them more sexually active.

Flibanserin, nicknamed the new “Women’s Viagra’ pill, has just been recommended for approval by an advisory panel with the U.S. Food and Drug Administration (FDA).

Sprout Pharmaceuticals in North Carolina (NC) are the makers of Flibanserin and twice they were turned down by the FDA - in 2010 and 2013- in having their ‘game-changing’ drug accepted for consumer use. It is widely anticipated that the FDA will give the full green light on the pill later this year.

Boosting a woman’s libido through the brain is the trick behind this new drug and many women hail it as a major breakthrough that should have been on the market years ago.

The Pink Pill Revolution

But this pill is pink, not blue, meaning there is a difference between what women and men take in order to enhance their sexual activity.

Viagra increases the blood flow to sexual organs for men, while Flibanserin increases dopamine and norepinephrine in women. 

“We are one step closer to bringing to market the first treatment option for the most common form of female sexual dysfunction,” says Cindy Whitehead, who is the COO for Sprout Pharmaceuticals in Raleigh, NC.

Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women is a “common form of sexual dysfunction,” according to Sprout Pharmaceuticals. Their website reports that the “condition has been medically recognized for more than 40 years and is characterized by a deficiency or absence of sexual fantasies and desire for sexual activity, which causes marked distress or interpersonal difficulty, and is not better accounted for by another disorder or to the effects of substance.”

At present one in three women in the U.S. suffer from low sexual desire, and even worse is that one in 10 are beyond stressed about having the problem.

Flibanserin has a few side effects: dizziness, fainting and nausea. And it may not work on all women.

Viagra For Women

Tami Rowen, a gynecologist and clinical instructor at the University of California, San Francisco/UC Berkley School of Public Health, says Flibanserin will certainly make a difference in the lives of women who lack sexual desires.

“Up to 40 per cent of women report having sexual problems, and about 12 per cent find the problems very bothersome,” says Rowen. “This equates to millions of women who suffer from female sexual dysfunction, the most common being hypoactive sexual desire disorder. To date there are no drugs to treat this condition.”

She adds, “Just like Viagra opened the door for men to talk about sexual health, the hope is that Flibanserin will allow women to discuss this often highly distressing problem—and have an option for treatment. This is an important development for women and for those of us who treat them.”

According to Sprout Pharmaceuticals, Flibanserin was tested in more than 11,000 women.

In a six-month, double-blind, placebo-controlled, parallel-group North American (USA and Canada) studies of premenopausal women with a mean age of 36 years, Flibanserin “consistently demonstrated a highly statistically significant difference over placebo on three key endpoints, including increase in sexual desire, decrease in distress from the loss of sexual desire and increase in the frequency of satisfying sex.”

Most women who were tested with the drug experienced it benefits within four to six weeks.

Will this new pill be widely utilized when it goes public? There is no doubt about it. Women also want to enjoy a healthy and fun sex life. It's great that they have a solution now and of course this new drug will get more women talking and learning about HSDD.

Welcome to the Pink Pill Revolution.